Paul Declerck

Prof. Paul J. Declerck obtained his Ph.D. in Pharmaceutical Sciences from the KU Leuven (Belgium) in 1984. After a post-doctoral training in the Laboratory of Biochemical Cytology (Prof. Dr. C. de Duve) at the Rockefeller University in New York he joined in 1986 the Center for Molecular and Vascular Biology (Prof. D. Collen) at the KU Leuven. In 1991 he was appointed professor of Pharmaceutical Biotechnology at the Faculty of Pharmaceutical Sciences. He became full professor in 1997. He is Research Director of the Laboratory for Therapeutic and Diagnostic Antibodies at the Department of Pharmaceutical and Pharmacological Sciences (KU Leuven). His research is focused on structure-function relationships of (recombinant) proteins and on the development of monoclonal antibodies for research, diagnostic and therapeutic purposes. He has expertise in the area of recombinant proteins, monoclonal antibody technology, biotechnology, drug development, structure-function relationship in proteins, biosimilars. Prof. Declerck has given numerous invited lectures at international meetings and has authored more than 230 scientific papers in peer-reviewed journals. He is Dean of the faculty of Pharmaceutical Sciences of the KU Leuven, president of the International Society for Fibrinolysis and Proteolysis, member of the Commission of Medicines for human use of the Belgian Federal Agency for Medicines and Health Products and member of various international scientific advisory boards.